Please note: This research was commissioned by Admedus and NDF Research will receive fees for undertaking it. dam I just found this but then again most research would be paid for by the company.
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-536
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.39 |
Change
0.080(0.44%) |
Mkt cap ! $353.4M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $18.13 | $57.43K | 3.129K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 481 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.39 | 486 | 1 |
View Market Depth
| Last trade - 15.18pm 02/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |